TLSA

Tiziana Life Sciences Announces Tv Interview With First Patient Dosed With Moderate Alzheimer’s Disease

时间：2025-02-11 22:15:00 市场： 美股 综合

关联： TLSA

Tiziana Life Sciences Announces Positive Results in Treating Spinal Cord Injury With Nasal Anti-Cd3

时间：2025-01-24 04:00:19 市场： 美股 综合

关联： TLSA

Tiziana Life Sciences: Reduction of Side Effects Seen With Discontinuation of Glp-1 Agonists With Nasal Anti-Cd3

时间：2025-01-10 21:02:58 市场： 美股 综合

关联： TLSA

Tiziana Announces Reduction of Side Effects Commonly Seen With Discontinuation of Glp-1 Agonists With Nasal Anti-Cd3

时间：2025-01-10 21:00:02 市场： 美股

关联： TLSA

Tiziana Life Sciences Announces Registered Direct Offering of up to Approximately $10 Million

时间：2024-10-31 10:29:42 市场： 美股 综合

关联： TLSA

Tiziana Life Sciences Announces Positive Results From Ozempic and Nasal Anti-Cd3 Combination Study

时间：2024-10-30 20:30:00 市场： 美股 综合

关联： TLSA

Tiziana Life Sciences - Entered Into Sale Agreement Relating to Issuance and Sale of Common Shares Offered by Prospectus Supplement

时间：2024-10-26 05:04:51 市场： 美股 综合

关联： TLSA